Cellectar Biosciences (NASDAQ:CLRB) reported its Q2 earnings results on Friday, August 5, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Cellectar Biosciences missed estimated earnings by 18.45%, reporting an EPS of $-1.22 versus an estimate of $-1.03.
Revenue was down $0 from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0 which was followed by a 2.94% drop in the share price the next day.
To track all earnings releases for Cellectar Biosciences visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.